Trading Statement Aspen Pharmacare Holdings Limited (Incorporated in the Republic of South Africa) (Registration number 1985/002935/06) Share code: APN & ISIN: ZAE000066692 ("Aspen") Trading Statement Aspen shareholders are hereby advised that normalised headline earnings per share (“NHEPS”) from continuing operations, headline earnings per share and earnings per share for the 6 months ended 31 December 2014 are expected to exceed those reported in the comparative period, ended 31 December 2013, within the following ranges: Measure Range Cents per share Cents per share in Notes the comparative period - 31 December 2013 NHEPS from 19% to 24% 557.0 to 580.4 468.0 1 continuing operations Headline earnings per 25% to 30% 530.2 to 551.5 424.2 2 share Earnings per share 24% to 29% 525.0 to 546.2 423.4 2 Notes: 1. NHEPS from continuing operations comprises headline earnings per share adjusted for specific non-trading items. NHEPS is the primary measure used by management to assess Aspen’s underlying financial performance. 2. The growth in headline earnings per share and earnings per share exceeds NHEPS from continuing operations as a result of add backs to NHEPS in the prior 6 months for significant transaction costs relating to new business acquisitions. The favourable results reflected above are despite the effect of material foreign exchange losses arising mainly as a consequence of the strengthening of the US Dollar against Aspen’s primary trading currencies. The financial results on which this trading announcement is based have not been reviewed or reported on by Aspen`s external auditors. Aspen`s interim results for the 6 months ended 31 December 2014 are scheduled to be published on SENS on 5 March 2015. Durban 26 February 2015 Sponsor: Investec Bank Limited Date: 26/02/2015 05:50:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.